PayPal sees encouraging growth from Venmo; shares surge after hours
Company beats expectations on quarterly earnings and revenue
All Posts in "Markets"
European bourses end the session in the red as global stocks turn lower
Novartis announces billion-dollar pharmaceutical deal
Chinese stocks notch best day since August as officials calm worries about market, economy
Shanghai and Shenzhen indexes book their best gains in about two months, but are on pace for the steepest monthly losses since 2016
Opinion: With crude above $70, it’s time to sell your oil stocks
From fracking stocks to Big Oil, there are few signs to encourage investors
PayPal earnings: Venmo progress could breathe life into stalled stock
Analysts are also looking for commentary on M&A, international growth
Chinese stock markets hit fresh 4-year low to lead Asian region lower
Nikkei slips, weighed by energy stocks; Korea’s central bank stays pat
EBay sues Amazon, accuses it of illegally poaching sellers
EBay claims Amazon scheme to exploit internal email system
Dow ends nearly 550 points higher as upbeat earnings send stocks soaring
Dow, S&P 500, Nasdaq have best day since March
Sterling slides after U.K. inflation print; dollar traders await Fed minutes
Currency markets kicked off Wednesday trade on a choppy note, as themes driving major pairs including Brexit and worries about Italy remained firmly in place.
Gold slips from multimonth high as dollar index firms
Stock weakness limits gold’s downside ahead of latest Fed snapshot
Despite cash infusion, Windtree still faces money running out within a year
Pain medicine biotech Latigo taps CRO founder for CMO role
Johnson & Johnson to buy heart failure implant company V-Wave for up to $1.7B
Talus Bio tacks on $11M to target hard-to-reach transcription factors
Pathalys raises $105M series B to prepare Japan-approved kidney disease drug for FDA
Denmark’s Adcendo signs $1B biobuck deal for Multitude’s anti-TF ADC
Merck & Co. bags one Kelun ADC for $37.5M, boots out another asset as pipeline tinkering continues
Avantor sells clinical services unit to private equity firm for $650M
‘We’re pretty prolific’: Lilly Catalyze360 looks to connect with emerging biotechs across ‘all areas’
FDA clears its first at-home blood test for syphilis